Business
New prototype therapy may repair IPF lung scarring by regenerating... - Pulmonary Fibrosis News
Researchers developed NZ-97, an inhalable drug that stimulates the growth of stem cells in the lungs, potentially repairing scarring in IPF.
By: Pulmonaryfibrosisnews.com
- Apr 28 2024
- 0
- 0 Views
Researchers have developed an inhalable prototype medicine that may be able to repair lung scarring caused by idiopathic pulmonary fibrosis (IPF) by stimulating the growth of stem cells directly in t… [+4405 chars]